# OnCo record paper-lindeman-lung-molecular-testing-guideline-jto-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lindeman-lung-molecular-testing-guideline-jto-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lindeman-lung-molecular-testing-guideline-jto-2018" ;
  schema:name "Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors"@en ;
  schema:description "Three professional bodies set out what every laboratory must test for in lung cancer, which sample types are acceptable, and when a blood test may stand in for a piece of tumour."@en ;
  schema:url <https://onco.cc/key-papers/paper-lindeman-lung-molecular-testing-guideline-jto-2018/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.jtho.2017.12.001>, <https://pubmed.ncbi.nlm.nih.gov/29396253/> ;
  schema:sameAs <https://doi.org/10.1016/j.jtho.2017.12.001> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Lindeman NI, Cagle PT, Aisner DL, et al." ;
  onco:related <https://onco.cc/biomarkers/egfr-t790m/>, <https://onco.cc/biomarkers/alk-fusion/>, <https://onco.cc/biomarkers/ros1-fusion/>, <https://onco.cc/biomarkers/met-ex14/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/cytogenetics-fish/>, <https://onco.cc/technologies/rna-seq/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/alk/>, <https://onco.cc/targets/ros1/>, <https://onco.cc/targets/ret/>, <https://onco.cc/targets/met/>, <https://onco.cc/targets/braf/>, <https://onco.cc/targets/kras/>, <https://onco.cc/targets/her2/> ;
  onco:pathways <https://onco.cc/pathways/rtk-activation/>, <https://onco.cc/pathways/nsclc-signalling/> ;
  onco:terms <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/fish/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/cfdna/>, <https://onco.cc/terms/biopsy/>, <https://onco.cc/terms/gene-fusion/> ;
  onco:journals <https://onco.cc/journals/journal-of-thoracic-oncology/> .